Kyongbo Pharmaceutical Co Ltd (214390) - Total Liabilities

Latest as of June 2026: ₩220.58 Billion KRW ≈ $149.48 Million USD

Based on the latest financial reports, Kyongbo Pharmaceutical Co Ltd (214390) has total liabilities worth ₩220.58 Billion KRW (≈ $149.48 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 214390 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Kyongbo Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Kyongbo Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Kyongbo Pharmaceutical Co Ltd asset portfolio.

Kyongbo Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kyongbo Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Perintis Triniti Properti PT JK:TRIN	Indonesia	Rp1.82 Trillion
Maywufa Co Ltd TW:1731	Taiwan	NT$1.02 Billion
Synergy Innovation Co. Ltd KQ:048870	Korea	₩62.55 Billion
MLG OZ Ltd AU:MLG	Australia	AU$174.09 Million
IFB Agro Industries Limited NSE:IFBAGRO	India	Rs2.87 Billion
Taeyang Metal Industrial Co Ltd KO:004105	Korea	₩443.01 Billion
Intech Biopharm Ltd TWO:6461	Taiwan	NT$1.34 Billion
Toma as PR:TOMA	Czech Republic	Kč964.46 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Kyongbo Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Kyongbo Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyongbo Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyongbo Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual total liabilities of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩173.80 Billion ≈ $117.78 Million	+26.19%
2024-12-31	₩137.73 Billion ≈ $93.34 Million	+12.97%
2023-12-31	₩121.92 Billion ≈ $82.63 Million	+25.90%
2022-12-31	₩96.84 Billion ≈ $65.63 Million	+6.09%
2021-12-31	₩91.28 Billion ≈ $61.86 Million	-6.08%
2020-12-31	₩97.18 Billion ≈ $65.86 Million	+9.62%
2019-12-31	₩88.65 Billion ≈ $60.08 Million	+22.09%
2018-12-31	₩72.61 Billion ≈ $49.21 Million	+14.60%
2017-12-31	₩63.36 Billion ≈ $42.94 Million	-14.76%
2016-12-31	₩74.33 Billion ≈ $50.37 Million	+2.29%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-27.11%
2014-12-31	₩99.70 Billion ≈ $67.57 Million	--

About Kyongbo Pharmaceutical Co Ltd

KO:214390 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$87.65 Million

₩129.34 Billion KRW

Market Cap Rank

#19768 Global

#1017 in Korea

Share Price

₩5410.00

Change (1 day)

+0.56%

52-Week Range

₩4945.00 - ₩8550.00

All Time High

₩19100.23